And the beat goes onis a refrain that kept rolling through my head after attending the symposium Tuesday hosted by the Womens Institute for a Secure Retirement (WISER) in Washington, D.C. The topic: retirement solutions for women.
I was honored to be invited by WISER President Cindy Hounsell, to kick off the discussion and was joined by Transamerica Center for....More>>>
Netflix Inc. (NASDAQ:NFLX) is bubbling, and one important lesson is that bubbles burst. A counter point is bubbles persist and you do not necessarily want to short the stock because you may be caught up in a short squeeze. I believe it is a great time to take profits in NFLX. My recommendation is to sell some of your stock holdings to preserve capital and/or take some profits. Strike while the iron....More>>>
Canadian Prime Minister Justin Trudeau has renewed his threat to scrap a potential deal to buy fighter jets from Boeing.
Trudeau called the U.S. plane manufacturer’s trade action against Canadian company Bombardier “unwarranted” and added that if Boeing (BA)continues the dispute, Canada won’t be buying Boeing’s F/A-18 Super Hornet fighter jets. The deal could....More>>>
Senate prepares to vote on skinny ACA change proposal
Vice President Breaks Health Bill Debate Tie
U.K. regulators set out plans for ensuring senior staff of financial-services firms can be held to account for misconduct on their watch, extending rules already in place for banks to almost all firms.
Novartis AG (NVS) said Monday that it has received approval from the European Commission for a blood cancer treatment known as Rixathon, a biosimilar version of Roche AG’s (RHHBY) blockbuster Rituxan that generated around $7.5 billion in sales last year.
Sandoz, the biosimilar division of Swiss drugmaker Novartis, said the approval allows for the use of Rixathon in Europe and....More>>>
Starbucks (NASDAQ:SBUX) is an incredibly well-run business with impressive fundamentals as a direct result. That’s it; no need to discuss about the atmosphere in the stores, rewards programs, Pokemon Go, or even Chinese market penetration. That is the job of the management. The company has proven its worth year after year through its strong fundamental growth.
Three of the early darlings of Web 2.0 have nearly died. Each has a stock price that has collapsed over the past two years, while the Nasdaq has jumped 18% to an all-time high. Yelp Inc. (NASDAQ: YELP), Groupon Inc. (NASDAQ: GRPN) and Twitter Inc. (NASDAQ: TWTR) shares have cratered. One reason the shares are down, aside from theirfinancial performance, is that no other company is likely to acquire....More>>>
On Friday, four out of ten of the worst performing small cap stocks had double digit losses due to announcing public stock offerings:
Medical device stock Transenterix Inc (NYSEMKT: TRXC) sank 40.37% after announcing a $24.9 million offeringand the pricing of its public offering of units, each consisting of one share of the Companys common stock, one Series A warrant to purchase one share....More>>>
Having worked with highly skilled traders of financial markets at a variety of money management organizations, I’ve noticed one distinctive marker of success: the great traders leverage one or more great strengths in their personalities and in their information processing. Those strengths differ from one exemplary money manager to another, but in each case some distinctive strength is evident.
Wells Fargo’s David Maris and team call Valeant Pharmaceutical International’s (VRX) earnings and guidance “worse than feared” and contend that the struggling specialty pharmaceutical company’s “debt problem [is] coming into focus.” They explain:
Our preliminary look at 1Q results leads us to believe that Valeant is performing....More>>>
Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that wo
Nike's (NKE) revenue slowdown over the last few quarters has been so remarkable that it has led to some serious soul-searching within the company. So much so, in fact, that the world's largest sporting apparel and footwear company has been forced to reassess its initial plan to hit $50 billion in
The Vienna OPEC meeting is imminent and the market is rife with speculation about the probable extension of the production cut deal. The November accord succeeded to recover the oil prices from the historical lows hit in Feb 2016. However, the crude market remains oversupplied and the need t